Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beatrice Maffeo

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Cancers|September 14, 2024
The Ubiquitin-Conjugating Enzyme E2 O (UBE2O) and Its Therapeutic Potential in Human Leukemias and Solid TumorsBeatrice Maffeo, Daniela Cilloni
International Journal of Molecular Sciences|September 9, 2023
A Leukemic Target with a Thousand Faces: The MitochondriaBeatrice Maffeo, Cristina Panuzzo, Amedeo Moraca, et al.
Blood and Lymphatic Cancer : Targets and Therapy|December 7, 2019
Strategies For Targeting Chronic Myeloid Leukaemia Stem CellsGiovanna Carrà, Antonio Cartellà, Beatrice Maffeo, et al.
Pharmaceuticals (Basel, Switzerland)|March 6, 2021
Non-Coding RNAs: The "Dark Side Matter" of the CLL UniverseMarcello Francesco Lingua, Giovanna Carrà, Beatrice Maffeo, et al.
Cellular and Molecular Life Sciences : CMLS|April 24, 2020
P53 vs NF-κB: the role of nuclear factor-kappa B in the regulation of p53 activity and vice versaGiovanna Carrà, Marcello Francesco Lingua, Beatrice Maffeo, et al.
International Journal of Molecular Sciences|October 26, 2024
Detection of <i>KIT</i> Mutations in Systemic Mastocytosis: How, When, and WhyDaniela Cilloni, Beatrice Maffeo, Arianna Savi, et al.
Cancers|March 19, 2020
Tumor Suppressors in Chronic Lymphocytic Leukemia: From Lost Partners to Active TargetsGiacomo Andreani, Giovanna Carrà, Marcello Francesco Lingua, et al.
Journal of Cellular and Molecular Medicine|December 11, 2019
Inhibition of bromodomain and extra-terminal proteins increases sensitivity to venetoclax in chronic lymphocytic leukaemiaGiovanna Carrà, Paolo Nicoli, Marcello Francesco Lingua, et al.
Blood Advances|November 5, 2025
UBE2O AS A KEY REGULATOR OF DRUG-INDUCED ERYTHROPOIESIS IN THE CONTEXT OF MYELODYSPLASTIC SYNDROMESBeatrice Maffeo, Cristina Panuzzo, Arianna Savi, et al.
Journal of Experimental & Clinical Cancer Research : CR|April 17, 2021
IκBα targeting promotes oxidative stress-dependent cell deathGiovanna Carrà, Giuseppe Ermondi, Chiara Riganti, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Cancers|September 14, 2024
The Ubiquitin-Conjugating Enzyme E2 O (UBE2O) and Its Therapeutic Potential in Human Leukemias and Solid TumorsBeatrice Maffeo, Daniela Cilloni
International Journal of Molecular Sciences|September 9, 2023
A Leukemic Target with a Thousand Faces: The MitochondriaBeatrice Maffeo, Cristina Panuzzo, Amedeo Moraca, et al.
Blood and Lymphatic Cancer : Targets and Therapy|December 7, 2019
Strategies For Targeting Chronic Myeloid Leukaemia Stem CellsGiovanna Carrà, Antonio Cartellà, Beatrice Maffeo, et al.
Pharmaceuticals (Basel, Switzerland)|March 6, 2021
Non-Coding RNAs: The "Dark Side Matter" of the CLL UniverseMarcello Francesco Lingua, Giovanna Carrà, Beatrice Maffeo, et al.
Cellular and Molecular Life Sciences : CMLS|April 24, 2020
P53 vs NF-κB: the role of nuclear factor-kappa B in the regulation of p53 activity and vice versaGiovanna Carrà, Marcello Francesco Lingua, Beatrice Maffeo, et al.
International Journal of Molecular Sciences|October 26, 2024
Detection of <i>KIT</i> Mutations in Systemic Mastocytosis: How, When, and WhyDaniela Cilloni, Beatrice Maffeo, Arianna Savi, et al.
Cancers|March 19, 2020
Tumor Suppressors in Chronic Lymphocytic Leukemia: From Lost Partners to Active TargetsGiacomo Andreani, Giovanna Carrà, Marcello Francesco Lingua, et al.
Journal of Cellular and Molecular Medicine|December 11, 2019
Inhibition of bromodomain and extra-terminal proteins increases sensitivity to venetoclax in chronic lymphocytic leukaemiaGiovanna Carrà, Paolo Nicoli, Marcello Francesco Lingua, et al.
Blood Advances|November 5, 2025
UBE2O AS A KEY REGULATOR OF DRUG-INDUCED ERYTHROPOIESIS IN THE CONTEXT OF MYELODYSPLASTIC SYNDROMESBeatrice Maffeo, Cristina Panuzzo, Arianna Savi, et al.
Journal of Experimental & Clinical Cancer Research : CR|April 17, 2021
IκBα targeting promotes oxidative stress-dependent cell deathGiovanna Carrà, Giuseppe Ermondi, Chiara Riganti, et al.
Pageof 1